Monday, December 17, 2018
Roche announced last week the launch of FoundationOne CDx, Foundation Medicines comprehensive companion diagnostic test for personalised cancer care in Singapore. According to the official media release, FoundationOne CDx supports clinicians in their decision-making by providing a clear, in-depth report that describes the unique genomic profile of a patients tumour as well as associated, approved
[ Read More ]To encourage healthcare technology innovation and update the 510(k) pathway, the regulatory agency said that it will soon release measures aimed to sunset predicate devices that are over a decade old. In the interest of promoting innovation, FDA Commissioner Dr. Scott Gottlieb and Dr. Jeff Shuren, director of the FDAs Center for Devices and Radiological
[ Read More ]The FDA is seeking public comments for a proposed framework that would allow the majority of apps and software released by pharmas that accompany a drug treatment to avoid lengthy premarket review submissions.According to a notice released last week, such software would be viewed as promotional labeling, and therefore only require submission to the FDAs
[ Read More ]The Food and Drug Administration’s recently issued draft document updating its premarket medical device cybersecurity guidance originally issued in 2014 contains several important provisions, says regulatory attorney Yarmela Pavlovic.”The 2014 guidance that FDA issued about premarket cybersecurity considerations was fairly sparse; it wasn’t particularly detailed,” Pavlovic notes in an interview with Information Security Media Group.
[ Read More ]In addition to releasing the proposed guidance this week, the FDA announced a formalized agreement with the Department of Homeland Security to implement a new framework for greater collaboration between the two agencies for addressing cybersecurity in medical devices.”From my vantage point, it looks like everyone in the medical device security community is happy to
[ Read More ]Cybersecurity threats and vulnerabilities in todays modern medical devices are evolving to become more apparent and more sophisticated, posing new potential risks to patients and clinical operations, said FDA Commissioner Scott Gottlieb, M.D. The FDA has been working to stay a step ahead of these changing cybersecurity vulnerabilities, including engaging with external stakeholders. In this
[ Read More ]Maryland-based RightEye now has clearance for its software that helps clinicians assess reading skills, brain health and functional vision.
[ Read More ]As part of a series of announcements around medical device cybersecurity, FDA Commissioner Scott Gottlieb, M.D., said the agency plans to update premarket guidance in the coming weeks to recommend that manufacturers include a cybersecurity “bill of materials.” The agency also issued a new “playbook” for health systems responding to an attack.
[ Read More ]In a statement Monday, FDA Commissioner Scott Gottlieb, M.D., says the efforts are aimed at addressing growing cybersecurity threats and potential related patient safety worries for network-connected medical devices.”As the number of cyberattacks has increased, we’ve heard concerns about the potential for cybercriminals to attack patient medical devices,” Gottlieb says.Cybersecurity researchers continue to identify device
[ Read More ]In a statement, Dr. Scott Gottlieb detailed his agencys ongoing cybersecurity efforts, which include the signing of two significant memoranda of understanding and discussions to facilitate collaboration across government agencies.
[ Read More ]
